{
    "ticker": "ENZ",
    "name": "Enzo Biochem, Inc.",
    "description": "Enzo Biochem, Inc. is a biotechnology company that operates in the fields of molecular diagnostics, therapeutic products, and life sciences. Founded in 1976, Enzo focuses on the development and commercialization of innovative products and services that aim to improve patient health and advance the understanding of diseases. The company is known for its proprietary technologies and products, including DNA and RNA extraction kits, diagnostic assays, and reagents for research and clinical laboratories. Enzo's diagnostics segment offers a wide range of testing solutions, particularly in areas such as infectious diseases, women's health, and oncology. Additionally, the company is actively engaged in the development of novel therapeutic approaches, including the use of its proprietary small molecule compounds for the treatment of various conditions. With a commitment to research and development, Enzo strives to enhance healthcare outcomes through its advanced technological platforms and high-quality products. The company has established a strong reputation in the biotech industry and continues to expand its product offerings to meet the evolving needs of healthcare professionals and patients worldwide.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "1976",
    "website": "https://www.enzo.com",
    "ceo": "Elazar Rabbani",
    "social_media": {
        "twitter": "https://twitter.com/enzobiochem",
        "linkedin": "https://www.linkedin.com/company/enzo-biochem-inc/"
    },
    "investor_relations": "https://www.enzo.com/investor-relations",
    "key_executives": [
        {
            "name": "Elazar Rabbani",
            "position": "CEO"
        },
        {
            "name": "Cynthia A. A. G. K. V. L. C. L. R. D. L. S. M. S.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Products",
            "products": [
                "Molecular Diagnostic Assays",
                "Infectious Disease Tests",
                "Oncology Tests"
            ]
        },
        {
            "category": "Therapeutic Products",
            "products": [
                "Small Molecule Compounds",
                "Research Reagents"
            ]
        }
    ],
    "seo": {
        "meta_title": "Enzo Biochem, Inc. | Biotechnology and Diagnostics",
        "meta_description": "Explore Enzo Biochem, Inc., a leader in biotechnology and molecular diagnostics. Discover our innovative products and solutions for healthcare.",
        "keywords": [
            "Enzo Biochem",
            "Biotechnology",
            "Molecular Diagnostics",
            "Healthcare",
            "Infectious Diseases",
            "Oncology"
        ]
    },
    "faq": [
        {
            "question": "What does Enzo Biochem specialize in?",
            "answer": "Enzo Biochem specializes in molecular diagnostics, therapeutic products, and life sciences."
        },
        {
            "question": "Who is the CEO of Enzo Biochem?",
            "answer": "Elazar Rabbani is the CEO of Enzo Biochem, Inc."
        },
        {
            "question": "Where is Enzo Biochem headquartered?",
            "answer": "Enzo Biochem is headquartered in New York, New York, USA."
        },
        {
            "question": "What are Enzo Biochem's main products?",
            "answer": "Enzo Biochem's main products include molecular diagnostic assays, infectious disease tests, and small molecule compounds."
        },
        {
            "question": "When was Enzo Biochem founded?",
            "answer": "Enzo Biochem was founded in 1976."
        }
    ],
    "competitors": [
        "IDXX",
        "LH",
        "DGX"
    ],
    "related_stocks": [
        "ABT",
        "BAX",
        "RMD",
        "TMO"
    ]
}